Gerassimos A Pangalis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi request reprint Massive intravascular hemolysis: a fatal complication of clostridium perfringens septicemia in a patient with acute myeloid leukemia
    George Vaiopoulos
    First Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Laikon General Hospital, Greece
    Leuk Lymphoma 45:2157-9. 2004
  2. ncbi request reprint Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders
    Gerassimos A Pangalis
    First Department of Internal Medicine and Department of Hematology, National and Kapodistrian University of Athens, Laikon General Hospital, 16 Sevastoupoleos Street, Athens 11526, Greece
    Clin Lymphoma 5:235-40. 2005
  3. ncbi request reprint Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma
    Theodoros P Vassilakopoulos
    Haematology Section, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
    Int J Radiat Oncol Biol Phys 59:765-81. 2004
  4. ncbi request reprint Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease
    Maria Christina Kyrtsonis
    Hematology Section and Research Laboratory, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece
    Eur J Haematol 72:252-8. 2004
  5. doi request reprint Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab
    Sotirios G Papageorgiou
    Second Department of Internal Medicine, Propaedeutic, Hematology Unit, National and Kapodistrian University of Athens, Medical School, University General Hospital Attikon, Haidari, Greece
    Hematol Oncol 31:10-7. 2013
  6. doi request reprint Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma
    Ipatia A Doussis-Anagnostopoulou
    Laboratory of Histology and Embryology, National and Kapodistrian University of Athens, Medical School, Athens, Greece
    Clin Cancer Res 14:1759-66. 2008
  7. ncbi request reprint Serum levels of soluble syndecan-1 in Hodgkin's lymphoma
    Theodoros P Vassilakopoulos
    First Department of Internal Medicine and Department of Haematology, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece
    Anticancer Res 25:4743-6. 2005
  8. ncbi request reprint Early-stage gastric MALT lymphoma: is it a truly localized disease?
    Marina P Siakantaris
    Department of Haematology, National and Kapodistrian University of Athens, Medical School, Laikon General Hospital, Athens, Greece
    Oncologist 14:148-54. 2009
  9. ncbi request reprint Non-gastric extra-nodal marginal zone lymphomas--a single centre experience on 76 patients
    Christina Kalpadakis
    Department of Haematology, University of Crete, Medical School, University Hospital of Heraklion, Heraklion Crete, Greece
    Leuk Lymphoma 49:2308-15. 2008
  10. ncbi request reprint Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders
    Gerassimos A Pangalis
    Haematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Semin Oncol 30:201-5. 2003

Collaborators

Detail Information

Publications49

  1. ncbi request reprint Massive intravascular hemolysis: a fatal complication of clostridium perfringens septicemia in a patient with acute myeloid leukemia
    George Vaiopoulos
    First Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Laikon General Hospital, Greece
    Leuk Lymphoma 45:2157-9. 2004
    ..We describe a fatal case of a 74-year old man with acute myeloid leukemia complicated by massive intravascular hemolysis due to Clostridium perfringens sepsis...
  2. ncbi request reprint Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders
    Gerassimos A Pangalis
    First Department of Internal Medicine and Department of Hematology, National and Kapodistrian University of Athens, Laikon General Hospital, 16 Sevastoupoleos Street, Athens 11526, Greece
    Clin Lymphoma 5:235-40. 2005
    ..Research in this field should continue to further clarify the disease entities that overlap with WM. New technology such as gene-expression profile techniques may contribute to this purpose...
  3. ncbi request reprint Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma
    Theodoros P Vassilakopoulos
    Haematology Section, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
    Int J Radiat Oncol Biol Phys 59:765-81. 2004
    ..To present our long-term experience regarding the use of chemotherapy plus low-dose involved-field radiotherapy (IFRT) for clinical Stage I-IIA Hodgkin's lymphoma...
  4. ncbi request reprint Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease
    Maria Christina Kyrtsonis
    Hematology Section and Research Laboratory, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece
    Eur J Haematol 72:252-8. 2004
    ..Neovascularisation and bone resorption are related to myeloma disease activity...
  5. doi request reprint Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab
    Sotirios G Papageorgiou
    Second Department of Internal Medicine, Propaedeutic, Hematology Unit, National and Kapodistrian University of Athens, Medical School, University General Hospital Attikon, Haidari, Greece
    Hematol Oncol 31:10-7. 2013
    ..Established risk factors for CNS involvement in aggressive lymphomas may not be helpful in assessing the risk of CNS recurrence in this disease. Routine CNS prophylaxis is not probably required in PMLBCL...
  6. doi request reprint Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma
    Ipatia A Doussis-Anagnostopoulou
    Laboratory of Histology and Embryology, National and Kapodistrian University of Athens, Medical School, Athens, Greece
    Clin Cancer Res 14:1759-66. 2008
    ....
  7. ncbi request reprint Serum levels of soluble syndecan-1 in Hodgkin's lymphoma
    Theodoros P Vassilakopoulos
    First Department of Internal Medicine and Department of Haematology, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece
    Anticancer Res 25:4743-6. 2005
    ..At 6 years, failure-free survival was 70 +/- 9% vs. 50 +/- 11% (p = 0.32) for patients with serum soluble syndecan-1 levels above or below the observed median value of 91 ng/ml...
  8. ncbi request reprint Early-stage gastric MALT lymphoma: is it a truly localized disease?
    Marina P Siakantaris
    Department of Haematology, National and Kapodistrian University of Athens, Medical School, Laikon General Hospital, Athens, Greece
    Oncologist 14:148-54. 2009
    ..The clinical significance of occult blood disease and the potential appropriate intervention need to be further investigated...
  9. ncbi request reprint Non-gastric extra-nodal marginal zone lymphomas--a single centre experience on 76 patients
    Christina Kalpadakis
    Department of Haematology, University of Crete, Medical School, University Hospital of Heraklion, Heraklion Crete, Greece
    Leuk Lymphoma 49:2308-15. 2008
    ..The 5- and 10-year progression free survival was 56% and 41%, respectively. The only feature associated with inferior outcome was disease localisation to the lung...
  10. ncbi request reprint Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders
    Gerassimos A Pangalis
    Haematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Semin Oncol 30:201-5. 2003
    ..Based on the former, diagnosis is usually easy. It may be harder in LPL cases not secreting IgM. We consider that WM should be, for the time being, handled as a separate entity. Further studies are necessary...
  11. ncbi request reprint Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease
    Theodoros P Vassilakopoulos
    First Dept of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Haematologica 91:32-9. 2006
    ..We aimed to evaluate the baseline clinicopathologic features, prognostic factors and outcome of a large series of consecutive patients with pure infradiaphragmatic HL...
  12. ncbi request reprint Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome
    Christina Kalpadakis
    Department of Haematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
    Anticancer Res 29:1811-6. 2009
    ..To determine the immunoglobulin variable heavy chain (IgVH) gene usage and somatic mutation patterns in a series of SMZL patients and to correlate these findings with the clinical features and outcome...
  13. ncbi request reprint Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab
    Maria Christina Kyrtsonis
    First Department of Internal Medicine and Department of Haematology, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece
    Eur J Haematol 77:300-3. 2006
    ..Apart from mild local pain during the injection, no other adverse effects were observed. In conclusion, rituximab can be safely administered intralesionally in patients with PCMZL and can produce disease remission...
  14. ncbi request reprint Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission
    Zacharoula Galani
    First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Anticancer Res 27:571-4. 2007
    ..This case is an interesting model of refractory MM extraosseous involvement, that a clinician should be aware of when carrying out differential diagnosis...
  15. ncbi request reprint A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma
    Gerassimos A Pangalis
    Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos Str, P O Box 14044, Athens 11510, Greece
    Leuk Lymphoma 44:635-44. 2003
    ..14). In conclusion, iCNOP was equally effective to CHOP in patients with ANHL, producing more leukopenia and febrile episodes, but less alopecia. The development of two cases of secondary AML in th e iCNOP arm is of concern...
  16. doi request reprint Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen
    Sotirios Sachanas
    Department of Hematology, Athens Medical Center Psychikon Branch, Laikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
    Leuk Lymphoma 52:387-93. 2011
    ..There were no serious side effects. These results show that the R-Chl combination could be an effective therapeutic option as first line treatment in MCL, especially for patients with indolent disease characteristics...
  17. ncbi request reprint Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
    Marie Christine Kyrtsonis
    Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Br J Haematol 137:240-3. 2007
    ..The 5-year disease-specific survival was 82% and 30% in patients with sFLCR lower than and equal or greater than the median, respectively (P = 0.0001). sFLCR was an independent prognostic factor...
  18. ncbi request reprint Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma
    Theodoros P Vassilakopoulos
    Haematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Blood 105:1875-80. 2005
    ..Patients with standard risk should be staged with unilateral biopsy, but patients with high risk may benefit from bilateral biopsy...
  19. pmc Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care
    Theodoros P Vassilakopoulos
    Department of Haematology, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens 11527, Greece
    Oncologist 17:239-49. 2012
    ..Rituximab-CHOP (R-CHOP) is the standard of care for diffuse large B-cell lymphoma, whereas efficacy in PMLBCL has not been adequately confirmed...
  20. doi request reprint CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)
    Marie Christine Kyrtsonis
    Hematology Section of the First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece
    Clin Lymphoma Myeloma Leuk 11:99-102. 2011
    ..0008 and, .00021 respectively). Moreover, CD138 expression was related to serum IgM levels in WM patients (P=.0006). In conclusion, CD138 expression may constitute an additional aid in the distinction between WM and SMZL...
  21. ncbi request reprint Hodgkin's lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy
    Theodoros P Vassilakopoulos
    Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, 16 Sevastoupoleos Street, Athens, Greece
    Eur J Haematol 68:289-98. 2002
    ....
  22. ncbi request reprint Adult T-cell leukemia/lymphoma (ATLL): report of two fully documented Hellenic patients
    Styliani I Kokoris
    Haematology Section, 1st Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laikon General Hospital of Athens, Greece
    Leuk Lymphoma 45:715-21. 2004
    ..In conclusion, the two aforementioned patients are the first fully documented ATLL patients described in Greece. Investigation for HTLV-I antibodies should be mandatory in all patients with T-cell lymphoproliferative disorders...
  23. doi request reprint Kikuchi's lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome
    Theodoros P Vassilakopoulos
    First Department of Internal Medicine and Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, 17 Ag Thoma Street, Goudi, Athens, 11527, Greece
    Rheumatol Int 30:925-32. 2010
    ..In this setting, autoimmune disorders, mainly lupus and APLS, should be considered and excluded by the appropriate laboratory work-up...
  24. ncbi request reprint Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymhoma
    Andreas Marnerides
    Department of Pathology, Laikon General Hospital, National and Kapodistrian University of Athens, Greece
    Anticancer Res 31:3585-94. 2011
    ..Increased proliferation rate may be associated with inferior outcome in patients with Hodgkin lymphoma (HL). Minichromosome maintenance proteins (MCMs) and D-type cyclins are essential for DNA replication...
  25. ncbi request reprint Immunotherapeutic and immunoregulatory drugs in haematologic malignancies
    Gerassimos A Pangalis
    First Department of Internal Medicine, First Department of Propedeutic Internal Medicine and Department of Hematology, National and Kapodistrian University of Athens Medical School, Laikon General Hospital, Athens, Greece
    Curr Top Med Chem 6:1657-86. 2006
    ..The addition of these agents in therapeutic regimens has improved considerably the treatment of hematological malignancies...
  26. ncbi request reprint The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma
    Theodoros P Vassilakopoulos
    Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Haematologica 87:701-8; discussion 708. 2002
    ..This study was undertaken to examine the impact of s beta(2)m on the prognosis of patients with HL...
  27. ncbi request reprint Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma
    Theodoros P Vassilakopoulos
    First Department of Internal Medicine and Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Leuk Lymphoma 47:1450-1. 2006
  28. ncbi request reprint A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations
    Penelope Korkolopoulou
    Department of Pathology, First Department of Internal Medicine, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
    Br J Haematol 122:900-10. 2003
    ..Furthermore, the prognostic significance of angiogenesis requires the concomitant assessment of MVD and the complexity of the microvascular network...
  29. pmc Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis,  Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance
    Georgia Levidou
    First Department of Pathology, Laikon Hospital, University of Athens, Medical School, 75 Mikras Asias Street, 11527 Athens, Greece
    Biomed Res Int 2014:251479. 2014
    ..VEGF and p-STAT-3 exerted a favorable effect on progression, which remained significant in multivariate analysis, thereby constituting potential outcome predictors in CLL patients...
  30. ncbi request reprint Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin
    Gerassimos A Pangalis
    National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, 16 Sevastoupoleos St, P O Box 14044, Athens 11510, Greece
    Haematologica 87:500-6. 2002
    ....
  31. ncbi request reprint B-chronic lymphocytic leukemia: practical aspects
    Gerassimos A Pangalis
    Hematology Section, 1st Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Hematol Oncol 20:103-46. 2002
    ..Supportive care is an important part of patient management and it involves restoring hypogammaglobulinemia and disease-related anemia by polyvalent immunoglobulin administration and erythropoietin respectively...
  32. ncbi request reprint Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph1+ acute myeloid leukemia
    Nora Athina Viniou
    First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
    Eur J Haematol 72:58-60. 2004
    ..The addition of imatinib mesylate led to a molecular remission, which is sustained for 10 months so far...
  33. ncbi request reprint Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon-alpha
    Marianna Politou
    First Department of Internal Medicine, University of Athens Medical School, Greece
    Nephrol Dial Transplant 19:733-5. 2004
  34. ncbi request reprint Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression
    Meletios A Dimopoulos
    Department of Clinical Therapeutics, University of Athens School of Medicine, Greece
    Leuk Lymphoma 45:2057-61. 2004
    ..We conclude that rituximab is an effective treatment modality for patients with WM. Patients with both low levels of monoclonal protein and normal albumin are the best candidates for treatment with standard dose rituximab...
  35. ncbi request reprint Treatment of relapsed or refractory Waldenström's macroglobulinemia with bortezomib
    Meletios A Dimopoulos
    Department of Clinical Therapeutics, Euroclinic Hospital, Athens, Greece
    Haematologica 90:1655-8. 2005
    ..Thus, this agent is worth studying in patients with Waldenström's macroglobulinemia (WM)...
  36. doi request reprint Primary adult-onset macrophage activation syndrome with multisystemic tissue phagocytosis
    Anastasios Andreopoulos
    1st Department of Internal Medicine and Department of Haematology, Laikon General Hospital, National Kapodistrian University of Athens, 17 Ag Thoma st, Athens, Greece
    Int J Hematol 86:394-6. 2007
    ..Similar cases necessitate further study for classification and management...
  37. ncbi request reprint The splenic form of mantle cell lymphoma
    Maria K Angelopoulou
    Hematology Section, First Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, 16 Sevastoupoleos Street, 11510 Athens, Greece
    Eur J Haematol 68:12-21. 2002
    ..To describe the clinical, immunophenotypic and molecular features, as well as the clinical course of patients with unusual presentation of mantle cell lymphoma (MCL) purely located to the spleen...
  38. ncbi request reprint Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma
    Nikolas Tsavaris
    Department of Pathophysiology, Laikon General Hospital, Athens University School of Medicine, Greece
    Anticancer Res 22:1845-8. 2002
    ....
  39. ncbi request reprint Reversible dilated cardiomyopathy associated with amphotericin B treatment
    Ioannis Moyssakis
    Department of Cardiology, Laikon General Hospital, Athens, Greece
    Int J Antimicrob Agents 25:444-7. 2005
    ..The clinical data from our cases and two similar cases reported in the literature suggest that the presence of other factors predisposing to cardiac dysfunction may facilitate the occurrence of this rare side effect...
  40. ncbi request reprint Primary effusion lymphoma in two HIV-negative patients successfully treated with pleurodesis as first-line therapy
    X Yiakoumis
    Department of Haematology, Iatriko Athinon, Psychicon Branch, 1st Kyriakidou Str, P Psychikon, 15452 Athens, Greece
    Anticancer Res 30:271-6. 2010
    ..We also perform a review of the relevant literature regarding the clinical data, treatment, and survival of PEL in HIV-negative patients...
  41. ncbi request reprint Correspondence re: M. Provencio, et al. the topoisomerase IIa expression correlates with survival in patients with advanced Hodgkin's lymphoma. Clin. Cancer Res., 9: 1406-1411, 2003
    Theodoros P Vassilakopoulos
    Clin Cancer Res 9:5430-1; author reply 5431. 2003
  42. ncbi request reprint Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
    Roger G Owen
    Leeds General Infirmary, Leeds, UK
    Semin Oncol 30:110-5. 2003
    ..Patients with clinical features attributable to IgM monoclonal gammopathy but no overt evidence of lymphoma are considered to constitute a distinct clinical group and the term "IgM-related disorders" is proposed...
  43. ncbi request reprint Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy
    Carlo Visco
    Department of Lymphoma and Myeloma, University of Texas, MD Anderson Cancer Center, Houston, USA
    Leuk Lymphoma 45:2085-92. 2004
    ..0001). In conclusion, high serum IL-10 is independently associated with inferior PFS in patients with HD treated with RT...
  44. doi request reprint Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib
    Konstantinos Anargyrou
    Department of Haematology, 251 General Air Force Hospital, Athens, Greece
    Haematologica 93:451-4. 2008
    ..This increase was significant in patients who responded to treatment. In conclusion, angiopoietin-1/angiopoietin-2 ratio normalization reflected response to bortezomib...
  45. ncbi request reprint CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome
    George Z Rassidakis
    Department of Lymphoma Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 20:1278-87. 2002
    ..Therefore, we correlated CD20 expression with presenting features and clinical outcome of untreated patients with classical HD...
  46. doi request reprint Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab
    Maria K Angelopoulou
    Leuk Lymphoma 49:1817-20. 2008
  47. ncbi request reprint BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome
    George Z Rassidakis
    Department of Lymphoma Myeloma, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Cancer Res 8:488-93. 2002
    ..Therefore, we correlated BAX expression with presenting features and clinical outcome in untreated patients with HD...
  48. ncbi request reprint BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens
    George Z Rassidakis
    Department of Lymphoma Myeloma, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Blood 100:3935-41. 2002
    ..We conclude that BCL-2 is frequently expressed by HRS cells in cHD and is associated with inferior FFS in patients treated with ABVD or equivalent regimens...
  49. ncbi request reprint Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome
    Marco Herling
    Department of Lymphoma and Myeloma, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 9:2114-20. 2003
    ..We correlated LMP-1 with presenting features, including serum interleukin 10 levels and clinical outcome...